Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Simplex Type 2”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00274300
What this trial is testing

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

Who this might be right for
HSV-2
PowderMed 36
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Testing effectiveness (Phase 2)Study completedNCT04386967
What this trial is testing

OH2 Injection in Solid Tumors

Who this might be right for
Solid TumorMelanoma
Binhui Biopharmaceutical Co., Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Testing effectiveness (Phase 2)Ended earlyNCT04637698
What this trial is testing

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Binhui Biopharmaceutical Co., Ltd. 5
Not applicableAvailableNCT05844436
What this trial is testing

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Who this might be right for
HSV
AiCuris Anti-infective Cures AG
Not applicableEnded earlyNCT00138320
What this trial is testing

Herpevac Neonatal Substudy

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableStudy completedNCT02910284
What this trial is testing

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 140
Not applicableUnknownNCT03180112
What this trial is testing

The Association Between Herpes Simplex Viruses and Autism

Who this might be right for
Autism Spectrum Disorder
Assiut University 80
Post-approval studies (Phase 4)Study completedNCT00723229
What this trial is testing

Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Who this might be right for
Genital Herpes
University of Washington 48
Not applicableStudy completedNCT00357812
What this trial is testing

The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)

Who this might be right for
Herpes Simplex Keratitis
University of Ulster 50
Not applicableStudy completedNCT01460433
What this trial is testing

Problems With Immune Recovery in the Gut Tissue

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 21
Testing effectiveness (Phase 2)Study completedNCT02300142
What this trial is testing

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04616443
What this trial is testing

OH2 Injection in Combination With HX008 for Melanoma.

Who this might be right for
Melanoma
Binhui Biopharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT01453075
What this trial is testing

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 31
Not applicableStudy completedNCT00495573
What this trial is testing

HSV-2 Shedding Resolution After Acyclovir Treatment

Who this might be right for
Genital Herpes
University of Washington 36
Not applicableStudy completedNCT00946556
What this trial is testing

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

Who this might be right for
Herpes Simplex Type Two InfectionHIV Infections
University of Toronto 30
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation